iPhone app iPad app Android phone app Android tablet app More

James Love

James Love

Posted: May 20, 2009 07:52 AM

Hillary and Obama Set to Kill Medical R&D Treaty at WHO Meeting


The most favorable explanation for what is going on this week in Geneva is that Hillary Clinton and Obama are not following what key Bush hold-overs are about to do. The less favorable explanation is that Secretaries Clinton (State) and Sebelius (HHS) and the Obama White House are closely working with PhRMA to kill any further discussions of a medical R&D treaty at the WHO.

The medical R&D treaty has been discussed by many governments at the WHO, and supported by a very long list of health, consumer and development NGOs, including MSF, Oxfam, Health Action International, HealthGap, the 80 member TransAtlantic Consumer Dialogue, Knowledge Ecology International, Essential Action, and others. (See earlier expressions of support here, here, here, and here).

At present, the United States government is the leading source of government funded medical R&D, through agencies such as the National Institutes of Health. In both absolute terms and as a percentage of GDP, no other country comes close.

Health groups want more spent on priority medical R&D, particularly in areas such as the development of new antibiotics and vaccines, or treatments for neglected diseases. Given the dominant role of the U.S. in funding medical R&D now, this would largely result in increased obligations for other countries, particularly those with high incomes.

There are is also discussion about possible sharing of the costs of independent clinical trials for the development and evaluation of new medicines, greater transparency of the R&D resource flows and outputs, the use of new incentive systems like innovation inducement prizes that de-link R&D incentives from drug pricing, and many other topics (see below).

The efforts to discuss new trade and business models for R&D have delighted public health groups, but alarmed PhRMA.

The WHO is governed by World Health Assembly (WHA), which meets once a year, and an Executive Board, which meets twice a year. The annual WHA meeting began on Monday, and ends on Friday. The U.S. government delegation that is following this issue includes representatives from the Department of State, the Department of Health and Human Services, and the United States Trade Representative. State (Hillary's Department) seems to be taking the lead.

The U.S. position has now been incorporated in a draft resolution written by the WHO secretariat, which is highly responsive to US pressure. The US does not have its name on the resolution, which is sponsored by the Delegations of Canada, Chile, Iran (Islamic Republic), Japan, Libyan Arab Jamahiriya, Norway and Switzerland. (Distributed to the 62nd WHA as document A62/A/Conf.Paper No.4)

The deal the US has pushed is to force developing countries to choose between (a) the medical R&D treaty or (b) the ability of the WHO to look at other intellectual property issues relating to access to medicines. Basically the US delegation has conceded that it cannot block all efforts to deal with access to medicines, but it wants to stop any discussions that would be more transformative, in terms of trade or business models for medical R&D, that are opposed by PhRMA.

Negotiators say Obama is following the Bush game plan even more aggressively than was done when Bush was president.


For context about what a medical R&D treaty might do, consider this recent proposal by four countries for possible topics:
  1. Coordination and facilitation of periodic global priority assessments--including estimates of funding needs--for R&D to address public health needs.
  2. Norms and mechanisms to ensure sustainable financing for R&D.
  3. Measures to facilitate, encourage, and otherwise stimulate new incentive schemes for R&D (such as medical innovation inducement prizes, advanced market commitments, openness dividends, and other new innovative approaches), with special attention to measures that de-link R&D incentives from product prices, and reward innovations that improve health outcomes.
  4. Possible governmental agreement to contribute to the global cost of R&D, considering each nation's level of development, size of economy and capacity to pay, in order to establish global norms for R&D contributions. Contributions should be allowed through multiple means.
  5. Global norms and best practices to facilitate access to government funded research.
  6. Norms and measures regarding the transparency of global medical innovation.
  7. Mechanisms to develop and improve innovative capacity for research and development, particularly in developing countries.
  8. Measures to facilitate encourage or otherwise stimulate the transfer of technology between developed and developing countries as well as among developing countries.
  9. Norms promoting the management of intellectual property rights in a manner that reconciles the public interest in access to knowledge and health-related innovation, including the R&D needs of developing countries and that protects public health and promotes access to medicines.
  10. Relevant measures to improve the delivery of and access to health products and medical devices.
  11. Mechanisms to monitor and evaluate both the performance of global R&D efforts and the implementation of the treaty, including appropriate reporting systems.
  12. Measures to more effectively achieve compliance with appropriate ethical standards for medical research.
The most favorable explanation for what is going on this week in Geneva is that Hillary Clinton and Obama are not following what key Bush hold-overs are about to do. The less favorable explanation i...
The most favorable explanation for what is going on this week in Geneva is that Hillary Clinton and Obama are not following what key Bush hold-overs are about to do. The less favorable explanation i...
 
 
  • Comments
  • 18
  • Pending Comments
  • 0
  • View FAQ
Comments are closed for this entry
View All
Favorites
Recency  | 
Popularity
This user has chosen to opt out of the Badges program
photo
breakingpoint
War is a Racket - Smedley Butler
06:19 PM on 05/20/2009
the government in India to told Pharm Companies too shove their high prices and patents - they're taking them, making them and charging very little because they said, "their citizens health is important"

And let's look at why drugs are dirt cheap in Canada, France, UK and Germany because the
"United States government is the leading source of government funded medical R&D"

yes, we the citizens in the US pay for the development, clinical and hand all the profit making results to the Phamr Co to produce, and theses countries benefit and the US tax payer subsidize these countries by paying the high price.

Our tax payer universities produce it, test it and then give it away with no financial benefit to the US citizens.

How dumb is that?
07:05 PM on 05/20/2009
You are right about that. It was one of the major contentions at the Davos WTO meet. There is also certain caps on life-saving drugs and what can be charged. I am mildly asthmatic : While living in USA i used Ventolin (GlaxoSmithCline) which now retails at $21.00. The same company, manufactures and markets it here in India for $3.00. The Indian FDA is pretty strict and the norms are almost similar to that of the FDA. So, why should doesn't GSK import it? It is extremely disheartening to see the right wing nuts, pharma companies and interest groups derail the Health Care overhaul.
This user has chosen to opt out of the Badges program
photo
breakingpoint
War is a Racket - Smedley Butler
07:54 PM on 05/20/2009
many of the parts to make these drugs are now produced in China so shopping over border shouldn't be a big deal. only the insurance and drug companies stand to lose profits and profits on health is immoral.

Further, most of the money to develop these drugs come from the US tax payer - one should ask why are we even paying let along twice and at such a high price.

The American People can have anything they want, they just don't seem to want much of anything.
05:48 PM on 05/20/2009
Obama knows he does not stand a chance for re-election. Hell he may very well want NO PART of a second term. He don't care. No one in Washington cares. The couldn't if they wanted to. They are already BOUGHT AND PAID FOR by the powers that be.
This user has chosen to opt out of the Badges program
photo
01:41 PM on 05/20/2009
"Hillary and Obama..."??? What the...??
Who is the boss? Who is the Prezident, the decision maker? "The Decider"?
Why are you slapping 'Hillary' in the headline?
photo
HUFFPOST BLOGGER
James Love
01:55 PM on 05/20/2009
Sebelius has not been in office very long, and is probably not aware of this. State is taking a lead. It would not happen without the support of the Department she heads.
This user has chosen to opt out of the Badges program
photo
02:27 PM on 05/20/2009
It is the other way around, it would not happen without the direction of the President.
The 'Department she heads' can not take a decision at a world organization like WHO without instructions or approval from the POTUS.
The President sets the policy, we are reminded all the time, so he should take credit for successes and be accountable for policy decissions, we should not try to assign blame to Hillary Clinton for an Obama administration decission we don't like.
01:21 PM on 05/20/2009
Paying all the money and letting others do what ever they want would be better.

When ever the White House doesn't just lay down let peeps walk all over them they are acting like Bush?

This is so one sided it's sickening.
HUFFPOST SUPER USER
zell
11:29 AM on 05/20/2009
Something, that we are not aware of, is going on concerning our president. I have no idea what it is; however, I do know that we must pray for him because he is a kind, decent man who when elected gave us no idea he would promote some policies of the previous administration more than the previous administration promoted some their own policies. The Bible tells us that "Prayer changes things." Now is the time for all of us to pray for our president. I don't know anything else to do.
12:17 PM on 05/20/2009
At this point, prayer may be all we have left.
01:15 PM on 05/20/2009
I'm gonna pray too, only I'm going to pray that this type of ignorance dies out shortly. I'm gonna pray that this myth Obama voters (full disclosure: I voted for him in the general election) keep selling themselves that the President doesn't really only care about corporations and retaining (and expanding) for himself the unprecedented current level of executive power unlawfully seized by the Cheney administration with the complicity of Congress and the U.S. Supreme Court.

I'm gonna pray that progressives one day wake up and realize they've been had, again. I'm gonna pray that folks realize that calling center-right corporatist oligarchs like Obama and Bill Clinton "liberals" is the realization of Orwellian doublespeak. Cont'd.
10:48 AM on 05/20/2009
WHAT THE.......????

Obama is being more Bush than Bush?

Okay, this is really the last straw. This one isn't just about American lives anymore, this is potentially jeopardizing life all around the world.